Sage Journals: Discover world-class research

Retricted access

Review article

First published 2019-9

Andexanet alfa: A Novel Factor Xa Inhibitor Reversal Agent

Jason Powell, James Taylor, Scott G. Garland

Annals of Pharmacotherapy

Open access

Research article

First published 2022

Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa

Joseph Lewis, Omer Iqbal, Walter Jeske [...]

Clinical and Applied Thrombosis/Hemostasis

Open access

Research article

First published 2020

Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin,Enoxaparin,and Fondaparinux by Andexanet Alfa

Fakiha Siddiqui, Alfonso Tafur, Emily Bontekoe [...]

Clinical and Applied Thrombosis/Hemostasis

Open access

Review article

First published 2019

Andexanet alfa for reversal of factor Xa inhibitor-associated anticoagulation

Elise Carpenter, Divita Singh, Eric Dietrich [...]

Therapeutic Advances in Drug Safety

Open access

Research article

First published 2024

Use of Andexanet Alfa for Factor Xa Inhibitor Reversal in US Verified Trauma Centers: A National Survey

Charles Fasanya, Abenámar Arrillaga, Catherine Caronia [...]

Clinical and Applied Thrombosis/Hemostasis

Retricted access

Case report

First published 2025-5

Perioperative risks associated with administration of andexanet alfa during emergency cardiac surgery with circulatory arrest

Ajami Gikandi, Jean M. Connors, Christoph G. Nabzdyk [...]

Perfusion

Retricted access

Review article

First published 2019-6

Andexanet Alfa: A Recombinant Modified Human Factor Xa Protein for Drug Reversal of Rivaroxaban and Apixaban

Irene Abuan, Kristine H. Wong, Benjamin Bolinske [...]

Journal of Pharmacy Technology

Open access

Research article

First published 2022

Costs and Healthcare Resource Utilization Associated with Idarucizumab or Andexanet Alfa Oral Anticoagulant Reversal in Patients Hospitalized with Life-Threatening Bleeds

Alex C. Spyropoulos, Bríain Ó Hartaigh, Zhun Cao [...]

Clinical and Applied Thrombosis/Hemostasis

Open access

Article commentary

First published 2025-2

Development of a Medication-Use Evaluation Template for Andexanet Alfa in the Reversal of Anticoagulation With Factor Xa Inhibitors

Toni Fera, Allison Burnett, Jessica Grandoni [...]

Journal of Pharmacy Practice

Open access

Research article

First published 2022

Andexanet Alfa Versus Prothrombin Complex Concentrates/Blood Products as Apixaban/Rivaroxaban Reversal Agents: A Survey Among Pediatric Hematologists

Vilmarie Rodriguez, Joseph Stanek, Bryce A. Kerlin [...]

Clinical and Applied Thrombosis/Hemostasis

Search results